Cadence launches first IV paracetamol in US
This article was originally published in Scrip
Executive Summary
Cadence Pharmaceuticals has launched in the US its intravenous formulation of paracetamol, Ofirmev (acetaminophen) – the first IV form of the pain medication in the US, which had gained FDA approval in November (scripintelligence.com, 8 November 2010).